Laura Sivitz

National Institute of Allergy and Infectious Diseases, NIH 

NIH-Led Scientists Find Antibodies that Prevent Most HIV Strains from Infecting Human Cells

Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory. The scientists also have demonstrated how one of these disease-fighting proteins accomplishes this feat. According to the scientists, these antibodies could be used to design improved HIV vaccines, or…

Drug Regimen with Short Pauses Controls HIV and Could Lower Costs, Toxicity

Antiretroviral drugs for HIV infection usually are taken daily, and interrupting treatment for long periods of time has proven detrimental. However, a clinical trial in Uganda has found that pausing antiretroviral therapy (ART) for just two days every week is at least as effective as taking ART continuously over a 72-week period. In addition, the…

New Study Seeks Best Ways to Prevent Mother-to-Child HIV Transmission, Preserve Maternal and Infant Health

How can we best curb the risk of HIV transmission from an infected pregnant woman to her baby during pregnancy and breastfeeding while preserving the health of mother and child? The new study PROMISE, for “Promoting Maternal-Infant Survival Everywhere,” is addressing this question. Funded by The National Institutes of Health (NIH), the study, which will…